Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. FUJIFILM Holdings Corporation
  6. News
  7. Summary
    4901   JP3814000000

FUJIFILM HOLDINGS CORPORATION

(4901)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FUJIFILM : United Digestive Selects Fujifilm Medical Systems as Exclusive Vendor of Choice to Offer Enhanced Endoscopic Services to its Patients

03/26/2021 | 06:18am EDT

Preeminent gastroenterology practice management company selects Fujifilm's industry-leading portfolio of endoscopic imaging solutions.

FUJIFILM Medical Systems U.S.A., Inc., a leading provider of endoscopic imaging and endosurgical solutions, and part of the greater Fujifilm Healthcare portfolio, announces that United Digestive's gastroenterologists are now using Fujifilm's portfolio of 700 series advanced endoscopes and Eluxeo Imaging Systems.

The decision to partner with Fujifilm and adapt their innovative endoscopic imaging technologies is in line with United Digestive's mission to support their gastroenterologists by providing them with the clinical and operational support that empowers them to focus on the patient and deliver the absolute best care.

'The investment we make in our technology is also an investment we make in the health and well-being of our patients,' said John Suh, M.D., MPH, Chief Medical Officer for United Digestive. 'Our partnership with Fujifilm is extremely positive, and we've received outstanding feedback from our clinicians on ELUXEO's strikingly impressive image resolution, as well as the performance they've experienced across the variety of Fujifilm endoscopes.'

'Their hands-on approach to implementation ensured each of our physicians was fully supported in order to deliver uninterrupted quality patient care,' added Suh. 'Fujifilm's commitment to providing exceptional service and support was a key factor as to why we selected them as the exclusive vendor of choice for all of our 15 endoscopy centers.'

'We're appreciative of the confidence United Digestive has instilled in Fujifilm by selecting us as their partner for endoscopic imaging solutions,' says Taisuke Fujita, General Manager of FUJIFILM Medical Systems U.S.A., Inc.-Endoscopy. 'We've seen time and time again that collaboration drives innovation, and we're grateful to work with an esteemed gastroenterology practice that is committed to leveraging superior technology that will provide better patient diagnosis and treatment that could inevitably save lives.'

Fujifilm's collaboration with United Digestive comes shortly after FUJIFILM Medical Systems U.S.A., Inc.'s announcement of achieving several global milestones and initiatives to advance the field of endoscopy and endoscopic health. Some of Fujifilm's latest developments in its global endoscopy business include artificial intelligence advancements, high-tech image capture, advanced data processing and notably, the launch of twelve new endoscopes, a variety of which the United Digestive is now using to enhance their affiliated clinical practices.

In the United States, colorectal cancer is the third leading cause of cancer-related deaths in men and in women, and the second most common cause of cancer deaths when men and women are combined. Although the rate of people being diagnosed with colon or rectal cancer each year has dropped overall since the mid-1980s, mainly because more people are getting screened and changing their lifestyle-related risk factors, the illness is expected to cause about 52,980 deaths during 2021. The industry encourages that individual's schedule appropriate and regular screenings, as many colorectal cancers can be prevented through regular screenings, and when found early, colorectal cancer is highly treatable.

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of innovative diagnostic imaging products and medical informatics solutions that meet and exceed the evolving needs of healthcare facilities today and into the future. It's ever expanding medical imaging solutions span digital radiography (DR), detectors, portables and suites, mammography systems with digital breast tomosynthesis, computed tomography solutions for oncology and radiology applications, technologically advanced flexible and surgical endoscopy and fluoroscopy solutions. Fujifilm enables interoperability through its Systems Integration offering as well as its comprehensive, AI-supported Synapse Enterprise Imaging portfolio, which includes the TeraMedica Division of Fujifilm. Fujifilm's in vitro diagnostics (IVD) portfolio includes clinical lab reagents, and biomarkers to assess the risk for the development of hepatocellular carcinoma in patients with chronic liver disease. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit www.fujifilmhealthcare.com.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2020, the company had global revenues of $22.1 billion, at an exchange rate of 109 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.

About United Digestive

United Digestive is an Atlanta-based physician practice management company focused on delivering value for GI physicians and gastroenterology practices nationwide. The company serves independent practices by leveraging advanced operational infrastructure and insights to reduce administrative burden, while supporting clinicians' objective to provide the highest-quality patient care. Their portfolio of affiliated practices include Atlanta Gastroenterology Associates, AGA's Pediatric & Adolescent Division, Gastroenterology Associates of Athens, and The Center for Digestive and Liver Health.

Contact:

Danielle Brown

914-574-3273

danielle.brown@fujifilm.com

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about FUJIFILM HOLDINGS CORPORATION
09/22FUJIFILM : The premium compact digital camera “FUJIFILM X100V” wins Bronze Awa..
PU
09/21APPILI THERAPEUTICS : Announces Agreement with FUJIFILM and Funding Support for Clinical T..
AQ
09/21FUJIFILM : Two Fujifilm Leaders Recognized as “Women Worth Watching” by Profil..
AQ
09/21FUJIFILM : North America Corporation Celebrates Newest FUJIFILM Creators
AQ
09/20APPILI THERAPEUTICS : Up 1% as Secures US$1 Million from FUJIFILM to Support Clinical Tria..
MT
09/20APPILI THERAPEUTICS : Secures US$1 Million from FUJIFILM to Support Clinical Trials for An..
MT
09/06FUJIFILM : Launches LTO Ultrium9 Data Cartridge -Magnetic tape storage media with maximum ..
PU
09/02Peptidream to Acquire Fujifilm Toyama Chemical's Radiopharmaceutical Business
MT
09/02FUJIFILM : launches FUJINON Lens GF35-70mmF4.5-5.6 WRá(Fujifilm)
PU
09/02FUJIFILM : launches mirrorless digital camera “FUJIFILM GFX50S II”á(Fujifilm)
PU
More news
Financials
Sales 2022 2 499 B 22 561 M 22 561 M
Net income 2022 172 B 1 557 M 1 557 M
Net Debt 2022 228 B 2 062 M 2 062 M
P/E ratio 2022 22,7x
Yield 2022 1,09%
Capitalization 3 915 B 35 363 M 35 349 M
EV / Sales 2022 1,66x
EV / Sales 2023 1,60x
Nbr of Employees 73 275
Free-Float 73,9%
Chart FUJIFILM HOLDINGS CORPORATION
Duration : Period :
FUJIFILM Holdings Corporation Technical Analysis Chart | 4901 | JP3814000000 | MarketScreener
Technical analysis trends FUJIFILM HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 9 792,00 JPY
Average target price 10 057,14 JPY
Spread / Average Target 2,71%
EPS Revisions
Managers and Directors
Teiichi Goto President, CEO & Representative Director
Kenji Sukeno Chairman
Takashi Iwasaki Director & Chief Technology Officer
Kunitaro Kitamura Independent Outside Director
Tatsuo Kawada Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
FUJIFILM HOLDINGS CORPORATION80.07%35 363
ABBOTT LABORATORIES13.59%220 485
MEDTRONIC PLC11.00%174 982
BECTON, DICKINSON AND COMPANY1.18%72 711
HOYA CORPORATION30.69%62 143
ALIGN TECHNOLOGY, INC.35.72%57 302